Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies
- Conditions
- Drug Therapy Management
- Registration Number
- NCT02703727
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
Oral anticoagulation therapy (OAC) entails a high potential for adverse events and strict adherence is needed.Thus, medication review and identification of safety issues and knowledge gaps about OAC is critically important. The polymedication check (PMC) is a reimbursed intermediate medication review focusing on adherence and medication management for Swiss primary care. Investigators aime to assess the impact of the PMC extended with a semi-structured interview focusing on OAC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- intake of an oral anticoagulant
- more than 3 drugs over at least 3 months prior to recruitment
- german language (written and spoken)
- medicines use in self management
- living in a nursing home
- provision of polymedication check in the past
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of Knowledge gaps about oral anticoagulation therapy 2 Weeks Knowledge about oral anticoagulation therapy will be assessed during the extended Polymedication check which includes 8 specific questions on oral anticoagulation knowledge. After 2 Weeks a follow-up telephone interview will be performed and the same 8 questions will be assessed.
- Secondary Outcome Measures
Name Time Method Medication possessio ratio (MPR) 12 Months Medication history from pharmacy software will be used to calculate the MPR of all drugs, retrospectively starting 12 months before the extended PMC takes place.
Trial Locations
- Locations (1)
Pharmaceutical Care Research Group University of Basel
🇨🇭Basel, Switzerland
Pharmaceutical Care Research Group University of Basel🇨🇭Basel, Switzerland